Nekisa Zakeri
@nekisazakeri.bsky.social
Clinician Scientist & Consultant Hepatologist. Wellcome Early Career Investigator. Interests in liver cancer & gamma delta T cells. Y-ILCA & HCC UK Committee.
My first post on bsky!
Really pleased to share our paper published today - comparing radiology vs. explant histology following bridging SABR for HCC. A small cohort but highlights the need for radiological criteria to more accurately reflect SABR treatment response in HCC 👉
rdcu.be/emMg2
Really pleased to share our paper published today - comparing radiology vs. explant histology following bridging SABR for HCC. A small cohort but highlights the need for radiological criteria to more accurately reflect SABR treatment response in HCC 👉
rdcu.be/emMg2
Stereotactic ablative radiotherapy for patients with hepatocellular carcinoma: analysis of post-treatment radiology and explant histology
BJC Reports - Stereotactic ablative radiotherapy for patients with hepatocellular carcinoma: analysis of post-treatment radiology and explant histology
rdcu.be
May 20, 2025 at 8:39 PM
My first post on bsky!
Really pleased to share our paper published today - comparing radiology vs. explant histology following bridging SABR for HCC. A small cohort but highlights the need for radiological criteria to more accurately reflect SABR treatment response in HCC 👉
rdcu.be/emMg2
Really pleased to share our paper published today - comparing radiology vs. explant histology following bridging SABR for HCC. A small cohort but highlights the need for radiological criteria to more accurately reflect SABR treatment response in HCC 👉
rdcu.be/emMg2